Literature DB >> 2307541

Cessation of autonomous proliferation of mouse lymphoma EL4 by fusion with a T cell line.

K Kubota1, H Katoh.   

Abstract

Benzanthracene-induced C57BL/6 (H-2b) mouse T-cell lymphoma EL4 (a thymidine kinase-deficient cell line) was fused by using polyethylene glycol with an Mlsa (Mls for minor lymphocyte stimulatory) antigen-dependent T cell line, which was designated G4 and had been derived from a C3H/He mouse (H-2k), and the fused cells were cultured in HAT medium. Although no growing cells appeared in most of these fusions, we consistently obtained growth-arrested H-2Kb-positive cells from the fused cell populations by the panning method. The cells were tetraploid and were able to proliferate in response to Mlsa antigen. Three H-2Kb-positive clones, isolated by limiting dilution from three different fusions, were shown to be EL4 x G4 hybrids, because (1) they had both H-2k and H-2b antigens; (2) each of the clones had one submetacentric chromosome which was a marker chromosome of EL4, and they were tetraploid with modal chromosome numbers of 74, 78, and 79, respectively; (3) they had 4 isozymes of both parental cells. These results indicate that EL4 lymphoma cells cease to proliferate when fused with T cell line G4. The malignant phenotype of lymphoma EL4 is thus suppressed at the level of cell transformation by the introduction of the G4 cell genome.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2307541     DOI: 10.1002/ijc.2910450328

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  2 in total

1.  Characterization of a surface membrane molecule expressed by natural killer cells in most inbred mouse strains: monoclonal antibody C9.1 identifies an allelic form of the 2B4 antigen.

Authors:  K Kubota; H Katoh; K Muguruma; K Koyama
Journal:  Immunology       Date:  1999-03       Impact factor: 7.397

Review 2.  Phenotypic changes in growth-arrested T cell hybrids: a possible avenue to produce functional T cell hybridoma.

Authors:  Koichi Kubota; Kazuya Iwabuchi
Journal:  Front Immunol       Date:  2014-05-19       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.